Punjab Chemists Announce Halt to Sale of Pregabalin, Other Habit-Forming Drugs; Decide to Return Existing Stocks
Decision comes amid intensified inspections and alleged harassment of chemists; around 27,000 wholesale and retail chemists may be affected
Zinnia Balli / Babushahi Network
Chandigarh, October 25, 2026: The Punjab Chemists Association (PCA) has announced a statewide decision to stop the sale of Pregabalin and other habit-forming medicines with immediate effect and has directed chemists to arrange for the return of existing stocks to wholesalers and distributors through authorised procedures.
The decision, communicated to association members on October 25, comes amid intensified inspections and enforcement action by the Punjab Food and Drug Administration (FDA) against the alleged misuse and illegal sale of prescription medicines.
The chemists have taken this decision in view of the situation that has emerged following the Jhotta murder case, in which all chemists have come under suspicion and are facing raids.
The move is expected to affect around 27,000 wholesale and retail chemists across Punjab.
Association cites difficulties faced by chemists
According to reports, the association has expressed concern over frequent inspections and action against chemists over discrepancies in purchase and sale records, bills and other documentation relating to medicines.
Association representatives have maintained that while they support action against illegal drug sales and those violating the law, licensed chemists should not be subjected to undue hardship for the actions of a few.
The association has also raised concerns over the reputation of legitimate chemists, who are required to maintain detailed records and comply with prescribed procedures while handling medicines that have the potential for misuse.
Existing stocks to be returned
The association has asked its members to stop selling the identified medicines and return existing stocks to wholesalers and distributors in accordance with applicable laws and authorised procedures.
The decision covers Pregabalin and other habit-forming medicines, including psychotropic drugs that have come under increased scrutiny because of concerns over their misuse.
Pregabalin is prescribed for certain medical conditions, including nerve pain and some seizure disorders. Its misuse has emerged as a major concern for authorities in Punjab.
Patients may face difficulties
The decision has raised concerns about the availability of medicines for patients who genuinely require them for treatment.
People receiving prescriptions for nerve pain, certain neurological conditions and other medical problems could face difficulties if authorised retail supplies become unavailable.
Association representatives have suggested that the government should consider making such medicines available through government hospitals, dispensaries and other authorised public healthcare outlets so that patients do not suffer.
Patients who are currently taking these medicines should consult their treating doctors about continued treatment or alternatives rather than stopping medication on their own.